The analysts forecast global synthetic biology workstation market to grow at a CAGR of 7.02% during the period 2018-2022. One trend in the market is growing number of startups in synthetic biology.
With the increasing number of venture capitalists willing to fund bio-based solutions related to environment or healthcare, there is a high growth potential for the global synthetic biology workstation market in the commercial sector.
Altering biological products at a genetic level for a variety of use across sectors such as energy, fuel, healthcare, and food is attracting many new researchers and engineers to venture into synthetic biology.
Major key players in the global synthetic biology workstation market: Hudson Robotics, Intrexon, Synthetic Genomics, Tecan, and Thermo Fisher Scientific, Biosero, Don Whitley Scientific, GenScript, Hamilton, LABCYTE, LGR, and Zymergen.
According to the synthetic biology workstation market report, one driver in the market is increasing applications of synthetic biology. The scope of synthetic biology in genetic engineering creates many opportunities in designing desired genes.
Gene designing facilitates several applications of synthetic biology in various fields such as medicine: biofuels, biochemicals, and other bio-based substitutes. Through synthetic biology techniques, genes can be manipulated to provide high throughput and efficiency.
Several companies, apart from biotechnological and pharmaceutical companies, are keen on applying synthetic biology to create high-yield products with limited resources for the plastic, chemicals, and energy sectors.
Report at www.reportsnreports.com/.aspx?name=1272906.